tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Esther Rajavelu, 55 are a BUY (82.09%), 6 are a SELL (8.96%), 6 are a HOLD (8.96%).
Analyst Esther Rajavelu, carries an average stock price target met ratio of 57.71% that have a potential upside of 32.44% achieved within 245 days. Previously, Esther Rajavelu worked at UBS.
Esther Rajavelu’s has documented 155 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 12-Aug-2025.
Analyst best performing recommendations are on VNDA (VANDA PHARMACEUTICALS).
The best stock recommendation documented was for VNDA (VANDA PHARMACEUTICALS) at 2/14/2019. The price target of $21 was fulfilled within 1 day with a profit of $0.88 (4.37%) receiving and performance score of 43.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$489
$32.96 (7.23%)
$296
2 days ago
(31-Oct-2025)
48/49 (97.96%)
$32.96 (7.23%)
437
Buy
$527
$70.96 (15.56%)
$329
2 days ago
(31-Oct-2025)
17/18 (94.44%)
$70.96 (15.56%)
256
Buy
$549
$92.96 (20.38%)
$384
3 days ago
(30-Oct-2025)
8/9 (88.89%)
$99.44 (22.12%)
108
Buy
$473
$16.96 (3.72%)
$348
20 days ago
(13-Oct-2025)
9/9 (100%)
$8.05 (1.73%)
27
Buy
$495
$38.96 (8.54%)
$345
27 days ago
(06-Oct-2025)
18/19 (94.74%)
$43 (9.51%)
240
Which stock is Esther Rajavelu is most bullish on?
Which stock is Esther Rajavelu is most reserved on?
What Year was the first public recommendation made by Esther Rajavelu?
